Imperva Announces First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- Key things to know ahead of SK Hynix’s blockbuster US listing
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
Needham & Company Raises PT Sharply as Imperva (IMPV) Raises Guidance
May 8, 2015 6:59 AM EDTNeedham & Company reiterates their Buy rating on Imperva, Inc. (NYSE: IMPV), and raised the price target to $67 (from $48), after a strong, and well above consensuses, March quarter. IMPV reported a revenue of $44.8m (well above $40.5m consensus), and a loss of $0.26 per share was smaller than the $0.38 loss expected. IMPV raised their June quarter consensus to $47-$49m and (0.20) to (0.24), which is... More
Oppenheimer Raises PT After Imperva's (IMPV) Strong 1Q Showing
May 8, 2015 6:38 AM EDTOppenheimer reiterates their Outperform rating on Imperva, Inc. (NYSE: IMPV), and raised their price target to $58 (from $55), after a strong 1Q15.IMPV reported revenue up 42% YoY to $44.8M, which bested Oppenheimer estimates of $40.5M. IMPV also reported a loss per share of $0.26, better than estimated... More
Imperva (IMPV) Tops Q1 EPS by 12c; Guides FY15
May 7, 2015 5:09 PM EDTImperva (NYSE: IMPV) reported Q1 EPS of ($0.26), $0.12 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $44.8 million versus the consensus estimate of $40.5 million.
Imperva sees FY2015 EPS of ($0.77)-($0.63), versus the consensus of ($0.85). Imperva sees FY2015 revenue of $202-207... More

